A detailed history of Motiv8 Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Motiv8 Investments LLC holds 5,499 shares of ABBV stock, worth $944,343. This represents 0.73% of its overall portfolio holdings.

Number of Shares
5,499
Previous 4,922 11.72%
Holding current value
$944,343
Previous $845 Million 28.57%
% of portfolio
0.73%
Previous 0.63%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $94,535 - $115,013
577 Added 11.72%
5,499 $1.09 Billion
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $18,574 - $21,691
120 Added 2.5%
4,922 $845 Million
Q1 2024

May 30, 2024

BUY
$159.82 - $182.1 $81,028 - $92,324
507 Added 11.8%
4,802 $874 Million
Q4 2023

May 30, 2024

BUY
$137.6 - $154.97 $590,992 - $665,596
4,295 New
4,295 $666 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Motiv8 Investments LLC Portfolio

Follow Motiv8 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motiv8 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motiv8 Investments LLC with notifications on news.